Logo
  • What we do
    • Our services
    • Drug Development Analytics
      • Early Phase
      • Late Phase
    • Imaging Operations
    • Post-Marketing
    • Consultancy
  • Technology & Innovation
    • Imaging Biomarkers
      • Radiological reads
      • Volumetric MRI
      • PET & SPECT
      • Advanced MRI
    • Data Platforms
      • TrialTracker
      • Assessa
    • Innovation & AI
      • Imaging AI
      • Disease Modelling AI
  • Resources
    • Publications
    • Blog
    • Webinars
  • Company
    • About Us
    • News
    • Careers
      • Current Opportunities
      • Recruitment privacy notice
    • Partnerships
    • Leadership
  • Investors
    • Share price
    • Investor Info
      • RNS News
      • Regulatory Email Alert
      • Analyst Research
      • Financial Calendar
      • Investor Videos
      • Investor Events
    • Shareholder Information
      • Our Board
      • Shareholder Info
      • Company Documents
    • Governance
      • AIM Rule 26
      • Oversight
      • Contacts & advisers
  • Contact us
  • What we do
  • Technology & Innovation
  • Resources
  • Company
  • Investors
  • Contact us
  • Our services
  • Drug Development Analytics
  • Imaging Operations
  • Post-Marketing
  • Consultancy
  • Early Phase
  • Late Phase
  • Imaging Biomarkers
  • Data Platforms
  • Innovation & AI
  • Radiological reads
  • Volumetric MRI
  • PET & SPECT
  • Advanced MRI
  • TrialTracker
  • Assessa
  • Imaging AI
  • Disease Modelling AI
  • Publications
  • Blog
  • Webinars
  • About Us
  • News
  • Careers
  • Partnerships
  • Leadership
  • Current Opportunities
  • Recruitment privacy notice
  • Share price
  • Investor Info
  • Shareholder Information
  • Governance
  • RNS News
  • Regulatory Email Alert
  • Analyst Research
  • Financial Calendar
  • Investor Videos
  • Investor Events
  • Our Board
  • Shareholder Info
  • Company Documents
  • AIM Rule 26
  • Oversight
  • Contacts & advisers
  1. Resources
  2. Publications
  3. Application of fully automatic Hippocampal sub-field segmentation volumes to standard resolution T1 MR Imaging in Alzheimer’s disease

Application of fully automatic Hippocampal sub-field segmentation volumes to standard resolution T1 MR Imaging in Alzheimer’s disease

Download
Date: 12/12/2022 Category:

Recent publications

  • Amyloid PET centiloid: impact of calibration and processing steps
  • MDS 2022 Poster – An automated AI-based framework for putamen volume measurement in Multiple System Atrophy
  • EHDN Imaging Working Group Presentation on new HD-IH Consortium
  • AD/PD 2021 Poster - Automatic segmentation using deep learning for the hippocampus
  • AD/PD 2021 Poster - An adaptive step detection algorithm for waist-worn wearable devices: A feasibility study in older adults

Archives

  • March 2023
  • January 2023
  • 2022
  • 2021
  • 2020
  • 2019

Cookie policy

We use cookies to understand more about who's visiting our website, and, where we can, to provide you with a more tailored service. You can change your cookie settings at any time.

Accept all cookies Manage cookie settings

What we do

Our services

Drug Development Analytics

Imaging Operations

Post-Marketing

Consultancy

Technology & Innovation

Imaging Biomarkers

Data Platforms

Innovation & AI

Company

About Us

Careers

Partnerships

Leadership

Investors

Share price

Investor Info

Shareholder Information

Governance

IXICO plc
4th Floor, Griffin Court
15 Long Lane
London
EC1A 9PN

VAT number 658 184014
Company number 03131723
registered in England & Wales

IXICO's Quality Management
System is certified to
ISO13485:2016

Cookie policy |
Terms and conditions |
Privacy policy

© 2023 IXICO plc | all rights reserved